{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:22:35Z","timestamp":1768252955071,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.dsx.2021.102199","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:32:31Z","timestamp":1625571151000},"page":"102199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hyperglucagonemia and impaired insulin sensitivity are associated with development of prediabetes and type 2 diabetes - A study from South India"],"prefix":"10.1016","volume":"15","author":[{"given":"Satyavani","family":"Kumpatla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizwana","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premalatha","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udyama","family":"Juttada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7481-9762","authenticated-orcid":false,"given":"Arutselvi","family":"Devarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-3937","authenticated-orcid":false,"given":"Vijay","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2021.102199_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(75)92375-2","article-title":"The essential role of glucagon in the pathogenesis of diabetes mellitus","volume":"1","author":"Unger","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2021.102199_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11892-014-0555-4","article-title":"Glucagon and type 2 diabetes: the return of the alpha cell","volume":"14","author":"Lund","year":"2014","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.dsx.2021.102199_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contribution of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2021.102199_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1463-1326.2011.01449.x","article-title":"The role of dysregulated glucagon secretion in type 2 diabetes","volume":"13","author":"D\u2019 Alessio","year":"2011","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.dsx.2021.102199_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2337\/diab.36.3.274","article-title":"Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics","volume":"36","author":"Baron","year":"1987","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.dsx.2021.102199_bib6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2217\/bmm-2016-0090","article-title":"The biology of glucagon and the consequences of hyperglucagonemia","volume":"10","author":"Wewer Albrechtsen","year":"2016","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.dsx.2021.102199_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12020-012-9867-9","article-title":"Impact of incretin on early-phase insulin secretion and glucose excursion","volume":"44","author":"Shen","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.dsx.2021.102199_bib8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jc.2015-3885","article-title":"Altered plasma levels of glucagon, GLP-1 and glicentin during OGTT in adolescents with obesity and type 2 diabetes","volume":"101","author":"Manell","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2021.102199_bib9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2337\/db16-0354","article-title":"Non-suppressed glucagon after glucose challenge as a potential predictor for glucose tolerance","volume":"66","author":"Wagner","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2021.102199_bib10","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s001250100003","article-title":"Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations","volume":"44","author":"Ahren","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2021.102199_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199201023260104","article-title":"Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance","volume":"326","author":"Mitrakou","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2021.102199_bib12","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/0026-0495(84)90089-1","article-title":"Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance","volume":"33","author":"Borghi","year":"1984","journal-title":"Metabolism"},{"key":"10.1016\/j.dsx.2021.102199_bib13","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1210\/jc.2006-1515","article-title":"Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion","volume":"92","author":"Abdul-Ghani","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2021.102199_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1463-1326.2011.01549.x","article-title":"Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity","volume":"14","author":"Knop","year":"2012","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.dsx.2021.102199_bib15","series-title":"Foundation ID: definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. In report of a WHO\/IDF consultation","year":"2006"},{"key":"10.1016\/j.dsx.2021.102199_bib16","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.2337\/db16-0240","article-title":"Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation","volume":"65","author":"Faerch","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2021.102199_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2021.102199_bib18","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.102199_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF00252262","article-title":"Risk factors for worsening to diabetes in subjects with impaired glucose intolerance","volume":"26","author":"Kadowaki","year":"1984","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2021.102199_bib20","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s00125-014-3264-2","article-title":"Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals","volume":"57","author":"Bagger","year":"2014","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.dsx.2021.102199_bib22","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1210\/clinem\/dgab019","article-title":"Impaired suppression of glucagon in obese subjects parallels decline in insulin sensitivity and beta-cell function","volume":"106","author":"Chen","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2021.102199_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00592-014-0555-5","article-title":"Alpha and beta cell abnormalities in heamoglobin A1c defined prediabetes and type 2 diabetes","volume":"51","author":"Calanna","year":"2014","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.dsx.2021.102199_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. from the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2021.102199_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.regpep.2010.05.011","article-title":"Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis","volume":"164","author":"Knop","year":"2010","journal-title":"Regul Pept"},{"key":"10.1016\/j.dsx.2021.102199_bib26","first-page":"193","article-title":"Plasma gastric inhibitory polypeptide and glucagon-like peptide-1 levels after glucose loading are associated with different factors in Japanese subjects","volume":"2","author":"Harada","year":"2011","journal-title":"J\u00a0Diabet. Invest."},{"key":"10.1016\/j.dsx.2021.102199_bib27","article-title":"High plasma glucagon levels correlate with waist-to-hip ratio, suprailiac skinfold thickness, and deep subcutaneous abdominal and intraperitoneal adipose tissue depots in nonobese asian Indian males with type 2 diabetes in North India","volume":"2017","author":"Anoop","year":"2017","journal-title":"J\u00a0Diabet. Res"},{"issue":"8","key":"10.1016\/j.dsx.2021.102199_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1507\/endocrj.EJ18-0372","article-title":"Basal glucagon hyperscretion and response to oral glucose load in prediabetes and mild type 2 diabetes","volume":"66","author":"Ichikawa","year":"2019","journal-title":"Endocr J"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121002198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121002198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:14:25Z","timestamp":1761729265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121002198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1871402121002198"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102199","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperglucagonemia and impaired insulin sensitivity are associated with development of prediabetes and type 2 diabetes - A study from South India","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102199"}}